Abstract |
Retroperitoneal lymphadenectomy remains an integral component in the multidisciplinary management of testicular cancer. Through the evolution of the procedure, continued refinements have led to diagnostic and therapeutic benefits as well as improvements in perioperative and long-term morbidity. This article discusses the surgical management of testicular cancer, specifically addressing the indications, controversies, and complications of retroperitoneal lymph node dissection for both low-stage and high-stage disease.
|
Authors | Tatum Tarin, Brett Carver, Joel Sheinfeld |
Journal | The Urologic clinics of North America
(Urol Clin North Am)
Vol. 38
Issue 4
Pg. 439-49, vi
(Nov 2011)
ISSN: 1558-318X [Electronic] United States |
PMID | 22045175
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Topics |
- Adult
- Age Factors
- Germinoma
(mortality, pathology, surgery)
- Humans
- Lymph Node Excision
(methods)
- Lymph Nodes
(pathology, surgery)
- Male
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local
(mortality, pathology, surgery)
- Neoplasm Staging
- Prognosis
- Retroperitoneal Space
(pathology, surgery)
- Risk Assessment
- Survival Analysis
- Testicular Neoplasms
(mortality, pathology, surgery)
- Treatment Outcome
- Young Adult
|